Delivery Order SPE2DB20D7059-SPE2DB25FPZC0
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the ROTARIX vaccine oral syringe 1.5 mL product. The contract has a ceiling value of $5,418.15 and a period of performance through May 7, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a $12,058 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the ROTARIX vaccine oral syringe 1.5 mL, with a completion date of May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,383.30 fixed-price delivery order is for the ROTARIX vaccine oral syringe 1.5ML, a critical medical product to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the ROTARIX vaccine oral syringe 1.5ML to the Defense Logistics Agency (DLA). The $21,531.21 firm fixed-price delivery order contract has an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $3,062.89 delivery order to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. This delivery order is for the supply of the ROTARIX vaccine in 1.5 ML oral syringes. The contract has a firm-fixed price pricing type and a completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,479.40, is for the delivery of ROTARIX VACCINE ORAL SYRINGE 1.5ML to support federal healthcare programs. The contract does not have a set-aside designation, indicating open competition. As a long-standing DLA vendor, Amerisourcebergen provides...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,796.22 firm-fixed-price delivery order is for the ROTARIX vaccine in 1.5ml oral syringes, with a completion date of December 10, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ROTARIX vaccine oral syringes (1.5 ml) to support the Defense Logistics Agency (DLA) Troop Support Medical program. The $4,544.70 firm fixed-price contract has a period of performance through December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,272.35 firm fixed-price delivery order is for the supply of ROTARIX vaccine oral syringes, 1.5 mL, with an ultimate completion date of December 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,251.67, is for the delivery of Rotarix oral vaccine syringes 1.5 ML. The contract is a firm fixed-price delivery order with a completion date of January 13, 2025. This award is not associated with a set-aside designation. Amerisourcebergen holds an Indefinite Delivery...